Summary
McKesson Corporation's 2008 Form 10-K report highlights its position as a large accelerated filer, indicating significant market capitalization and operational scale. The company's substantial market value, approximately $16.3 billion based on non-affiliate equity in September 2007, underscores its prominence in the healthcare industry. With over 277 million shares outstanding as of April 2008, McKesson demonstrates a broad shareholder base and active trading on the market.
Financial Highlights
30 data pointsBeta
Financial Statements
Beta
| Revenue | $101.70B |
| Cost of Revenue | $96.69B |
| Gross Profit | $5.01B |
| R&D Expenses | $347.00M |
| Operating Expenses | $3.53B |
| Operating Income | $1.48B |
| Net Income | $990.00M |
| EPS (Basic) | $3.40 |
| EPS (Diluted) | $3.32 |
| Shares Outstanding (Basic) | 291.00M |
| Shares Outstanding (Diluted) | 298.00M |
Key Highlights
- 1McKesson Corporation is a large accelerated filer, signifying its substantial size and market presence.
- 2The aggregate market value of common equity held by non-affiliates was approximately $16.3 billion as of September 2007.
- 3As of April 30, 2008, there were 277,279,250 shares of common stock outstanding.
- 4The report indicates that portions of the Registrant's Proxy Statement for its 2008 Annual Meeting of Stockholders are incorporated by reference into Part III.
- 5The filing structure follows standard SEC Form 10-K format, detailing Business, Risk Factors, Properties, Legal Proceedings, and Financial Information.